Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
149 participants
INTERVENTIONAL
2011-06-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms
NCT01728610
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119
Multi Strain Probiotic Preparation in Patients With Irritable Bowel Syndrome
NCT04662957
Probiotics for Irritable Bowel Syndrome
NCT01151657
The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome
NCT03986476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotic low
Lower dose of probiotic supplement
Probiotic supplement
A single strain probiotic supplement given at two doses
Placebo
Probiotic supplement
A single strain probiotic supplement given at two doses
Probiotic high
Higher dose of probiotic supplement
Probiotic supplement
A single strain probiotic supplement given at two doses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotic supplement
A single strain probiotic supplement given at two doses
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danisco
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arthur Ouwehand, PhD
Role: STUDY_CHAIR
Danisco
Anna Lyra, PhD
Role: STUDY_DIRECTOR
Danisco
Lea Veijola, MD
Role: PRINCIPAL_INVESTIGATOR
Helsinki Health Centre
Sampo Lahtinen, PhD
Role: STUDY_CHAIR
Danisco
Anneli Tarpila, PhD
Role: STUDY_DIRECTOR
Danisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herttoniemi Hospital
Helsinki, Helsinki, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IBS2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.